ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Internal Medicine

Top Internal Medicine Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
GREGORY ZARCONE D.O.

Internal Medicine

28,847

$1.81M

1193
848 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

24%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$63
Average prescription price

Avg: $67

NEHME ALKARRA MD

Internal Medicine

28,502

$1.51M

893
635 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

35%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$53
Average prescription price

Avg: $67

PATRICIA SALVATO M.D.

Internal Medicine

28,382

$4.45M

908
256 are 65+

29%
patients receiving schedule two controlled substances

Avg: 1%

45%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 27%

$157
Average prescription price

Avg: $67

JAMES RACE

Internal Medicine

27,957

$1.55M

1066
719 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

30%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$55
Average prescription price

Avg: $67

ROBERT VOGEL M.D.

Internal Medicine

27,854

$1.58M

833
714 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

20%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$57
Average prescription price

Avg: $67

AYHAM SHNEKER MD

Internal Medicine

27,337

$1.53M

972
723 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

22%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$56
Average prescription price

Avg: $67

BRENDA VOZZA ZEID MD

Internal Medicine

26,658

$1.54M

781
569 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

22%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$58
Average prescription price

Avg: $67

ELIAS KANAAN MD

Internal Medicine

26,583

$1.71M

1109
895 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

11%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 27%

$64
Average prescription price

Avg: $67

THANDAVARAJAN GOPALAKRISHNAN M.D.

Internal Medicine

26,473

$1.63M

639
494 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

34%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$62
Average prescription price

Avg: $67

AMAN JAFAR MD

Internal Medicine

26,212

$1.88M

835
514 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 27%

$72
Average prescription price

Avg: $67

LENIN PINNAMANENI M.D.

Internal Medicine

26,177

$1.23M

743
541 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

38%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$47
Average prescription price

Avg: $67

JOSE PENA M.D.

Internal Medicine

25,799

$1.92M

1929
1488 are 65+

1%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$74
Average prescription price

Avg: $67

DEEPAK PATEL MD

Internal Medicine

25,552

$1.32M

708
548 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$52
Average prescription price

Avg: $67

BURCHAM FUQUA

Internal Medicine

25,056

$874K

979
829 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 27%

$35
Average prescription price

Avg: $67

JITENDRA BHATT M D

Internal Medicine

25,043

$1.36M

778
654 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

27%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$54
Average prescription price

Avg: $67

RAVI SREERAMA M.D.

Internal Medicine

25,035

$1.07M

622
430 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

29%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 27%

$43
Average prescription price

Avg: $67

ISAAC CHITRIT M.D.

Internal Medicine

24,946

$760K

966
807 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

18%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 27%

$30
Average prescription price

Avg: $67

ZAHID ZAFAR M.D.

Internal Medicine

24,917

$1.36M

1105
925 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

20%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$55
Average prescription price

Avg: $67

ORVILLE CERNA M.D.

Internal Medicine

24,903

$1.46M

893
732 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

25%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 27%

$59
Average prescription price

Avg: $67

ALFRED BERWICK MD

Internal Medicine

24,866

$1.33M

1092
1014 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

12%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$53
Average prescription price

Avg: $67

FIROOZEH KAR M.D.

Internal Medicine

24,815

$1.4M

508
446 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

32%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$57
Average prescription price

Avg: $67

JACQUELINE CARRUTHERS M.D.

Internal Medicine

24,550

$1.78M

819
540 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

22%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 27%

$73
Average prescription price

Avg: $67

WALTER HEWELL MD

Internal Medicine

24,313

$1.31M

744
554 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

27%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$54
Average prescription price

Avg: $67

EDWARD BATES MD

Internal Medicine

24,255

$1.11M

1012
801 are 65+

1%
patients receiving schedule two controlled substances

Avg: 1%

26%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$46
Average prescription price

Avg: $67

ENRIQUE RODRIGUEZ M.D.

Internal Medicine

24,135

$1.51M

1038
715 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

29%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$63
Average prescription price

Avg: $67

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank